chr1-43992614-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000372318.8(CCDC24):āc.394T>Cā(p.Phe132Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000372318.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC24 | NM_152499.4 | c.394T>C | p.Phe132Leu | missense_variant | 4/9 | ENST00000372318.8 | NP_689712.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC24 | ENST00000372318.8 | c.394T>C | p.Phe132Leu | missense_variant | 4/9 | 1 | NM_152499.4 | ENSP00000361392.3 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251394Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135892
GnomAD4 exome AF: 0.000309 AC: 452AN: 1461866Hom.: 0 Cov.: 33 AF XY: 0.000293 AC XY: 213AN XY: 727234
GnomAD4 genome AF: 0.000177 AC: 27AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.394T>C (p.F132L) alteration is located in exon 4 (coding exon 3) of the CCDC24 gene. This alteration results from a T to C substitution at nucleotide position 394, causing the phenylalanine (F) at amino acid position 132 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at